BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 38611037)

  • 1. Review of Prodrug and Nanodelivery Strategies to Improve the Treatment of Colorectal Cancer with Fluoropyrimidine Drugs.
    Sarkar S; Kiren S; Gmeiner WH
    Pharmaceutics; 2024 May; 16(6):. PubMed ID: 38931855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Therapeutic Efficacy of the Nanoscale Fluoropyrimidine Polymer CF10 in a Rat Colorectal Cancer Liver Metastasis Model.
    Okechukwu CC; Ma X; Sah N; Mani C; Palle K; Gmeiner WH
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Antitumor Activity of the Fluoropyrimidine Polymer CF10 in Preclinical Colorectal Cancer Models through Distinct Mechanistic and Pharmacologic Properties.
    Gmeiner WH; Dominijanni A; Haber AO; Ghiraldeli LP; Caudell DL; D'Agostino R; Pasche BC; Smith TL; Deng Z; Kiren S; Mani C; Palle K; Brody JR
    Mol Cancer Ther; 2021 Mar; 20(3):553-563. PubMed ID: 33361273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with
    Haber AO; Jain A; Mani C; Nevler A; Agostini LC; Golan T; Palle K; Yeo CJ; Gmeiner WH; Brody JR
    Mol Cancer Res; 2021 Apr; 19(4):565-572. PubMed ID: 33593942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response Monitoring with [
    Heskamp S; Heijmen L; Gerrits D; Molkenboer-Kuenen JDM; Ter Voert EGW; Heinzmann K; Honess DJ; Smith DM; Griffiths JR; Doblas S; Sinkus R; Laverman P; Oyen WJG; Heerschap A; Boerman OC
    Mol Imaging Biol; 2017 Aug; 19(4):540-549. PubMed ID: 27798786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10.
    Gmeiner WH; Miller LD; Chou JW; Dominijanni A; Mutkus L; Marini F; Ruiz J; Dotson T; Thomas KW; Parks G; Bellinger CR
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32224870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment.
    Gmeiner WH
    Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of benzofuran piperazine derivatives as potential anticancer agents.
    Schumacher TJ; Sah N; Palle K; Rumbley J; Mereddy VR
    Bioorg Med Chem Lett; 2023 Sep; 93():129425. PubMed ID: 37557926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects.
    Gmeiner WH; Okechukwu CC
    Cancer Drug Resist; 2023; 6(2):257-272. PubMed ID: 37457133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer.
    Mani C; Acharya G; Saamarthy K; Ochola D; Mereddy S; Pruitt K; Manne U; Palle K
    Breast Cancer Res; 2023 Apr; 25(1):44. PubMed ID: 37081516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival improvement for patients with metastatic colorectal cancer over twenty years.
    Zeineddine FA; Zeineddine MA; Yousef A; Gu Y; Chowdhury S; Dasari A; Huey RW; Johnson B; Kee B; Lee MS; Morelli MP; Morris VK; Overman MJ; Parseghian C; Raghav K; Willis J; Wolff RA; Kawaguchi Y; Vauthey JN; Sun R; Kopetz S; Shen JP
    NPJ Precis Oncol; 2023 Feb; 7(1):16. PubMed ID: 36781990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receipt of Targeted Therapy and Survival Outcomes in Patients With Metastatic Colorectal Cancer.
    Koroukian SM; Booker BD; Vu L; Schumacher FR; Rose J; Cooper GS; Selfridge JE; Markt SC
    JAMA Netw Open; 2023 Jan; 6(1):e2250030. PubMed ID: 36656585
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.